Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Myelodysplastic syndrome+2

Not yet recruiting

Registered drugNo placebo

Safety and tolerability study of S-241656 with posaconazole in patients with AML, MDS/AML or CMML

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Posaconazole

Contact Research Centre

Myelodysplastic syndrome+2

Not yet recruiting

Registered drugNo placebo

Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Myelodysplastic syndrome+1

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Hydrocortisone

Contact Research Centre

Myelodysplastic syndrome+1

Not recruiting

InvestigationalNo placebo

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride

Contact Research Centre

Myelodysplastic syndrome+1

Not recruiting

Registered drugNo placebo

Study of Natural Killer Cells and Aldesleukin for Patients with Acute Myeloid Leukemia

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Aldesleukin

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Myelodysplastic syndrome+1

Not recruiting

InvestigationalNo placebo

Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Emavusertib

Contact Research Centre

Myelodysplastic syndrome+2

Not recruiting

Registered drugNo placebo

Study on Continued Treatment with Sabatolimab for Adults with High-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Unfit for Chemotherapy

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

InvestigationalNo placebo

Study of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Myelodysplastic syndrome+1

Not recruiting

Registered drugNo placebo

Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Busulfan

Contact Research Centre

Myelodysplastic syndrome+1

Not recruiting

Registered drugNo placebo

Study on Molidustat and Ivosidenib for Adults with Relapsed or Refractory IDH1-Mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ivosidenib

Contact Research Centre

Myelodysplastic syndrome+1

Not recruiting

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate

Contact Research Centre

Find therapies in clinical trials near you – page 3

53 trials match your criteria

Myelodysplastic syndrome+2

Safety and tolerability study of S-241656 with posaconazole in patients with AML, MDS/AML or CMML

Myelodysplastic syndrome+2

Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

Myelodysplastic syndrome+1

Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure

Myelodysplastic syndrome+1

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Myelodysplastic syndrome+1

Study of Natural Killer Cells and Aldesleukin for Patients with Acute Myeloid Leukemia

Myelodysplastic syndrome

Study of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment

Myelodysplastic syndrome+1

Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Myelodysplastic syndrome+2

Study on Continued Treatment with Sabatolimab for Adults with High-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Unfit for Chemotherapy

Myelodysplastic syndrome

Study of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes

Myelodysplastic syndrome+1

Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

Myelodysplastic syndrome+1

Study on Molidustat and Ivosidenib for Adults with Relapsed or Refractory IDH1-Mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome

Myelodysplastic syndrome+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.